StockData
Zomedica Corp. logo

Zomedica Corp. (ZOMDF) stock

ZOMDFOTCPharmaceutical PreparationsFiscal year ends December 31
Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Nov 4, 2026Score 10/30
$0.08−0.00 (-0.55%)

Close on Oct 19, 2026Market cap $77.40MP/E –Yield –

Zomedica profit margin

Profit margin (net margin) is net income as a percentage of revenue.

Zomedica's profit margin for the twelve months ending Sep 30, 2026 was -41.4%. For fiscal 2025 it was -255.6%, against -172.2% the year before. The highest annual figure on record is -89.9% in fiscal 2022.

Annual profit margin

PeriodPeriod endValueChange (pts)
FY2025Dec 31, 2025-255.6%−83.4
FY2024Dec 31, 2024-172.2%−35.1
FY2023Dec 31, 2023-137.1%−47.2
FY2022Dec 31, 2022-89.9%+354.9
FY2021Dec 31, 2021-444.8%–

Quarterly profit margin

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange (pts)
Q3 FY2026Sep 30, 2026-32.0%+43.6
Q2 FY2026Jun 30, 2026-39.6%+66.7
Q1 FY2026Mar 31, 2026-51.5%+930.1
Q4 FY2025Dec 31, 2025-43.3%+47.9
Q3 FY2025Sep 30, 2025-75.6%+20.1
Q2 FY2025Jun 30, 2025-106.2%+284.1
Q1 FY2025Mar 31, 2025-981.7%−835.4
Q4 FY2024Dec 31, 2024-91.1%+214.3
Q3 FY2024Sep 30, 2024-95.7%−88.0
Q2 FY2024Jun 30, 2024-390.3%−303.1
Q1 FY2024Mar 31, 2024-146.3%−29.8
Q4 FY2023Dec 31, 2023-305.4%−259.8
Q3 FY2023Sep 30, 2023-7.7%+96.8
Q2 FY2023Jun 30, 2023-87.2%+37.0
Q1 FY2023Mar 31, 2023-116.5%−11.5
Q4 FY2022Dec 31, 2022-45.6%+35.0
Q3 FY2022Sep 30, 2022-104.6%+27486.7
Q2 FY2022Jun 30, 2022-124.2%+29319.6
Q1 FY2022Mar 31, 2022-105.0%+28730.8
Q4 FY2021Dec 31, 2021-80.6%–
Q3 FY2021Sep 30, 2021-27591.3%–
Q2 FY2021Jun 30, 2021-29443.8%–
Q1 FY2021Mar 31, 2021-28835.7%–

More Zomedica figures

See a number that looks wrong?